Mebucaïne N, Lutschtabletten

7680662560024 CH-66256 Lutschtabletten
Mebucaïne N, Lutschtabletten
Mebucaïne N, Lutschtabletten
Mebucaïne N, Lutschtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Lutschtabletten
Galenic group
Lutschtabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/02/2025
Patient information leaflet
Français
01/02/2025
Patient information leaflet
Italien
01/02/2025
Summary of Product Characteristics
Allemand
01/02/2025
Summary of Product Characteristics
Français
01/02/2025
Summary of Product Characteristics
Italien
01/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance AROMA
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.107 G Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
66256
Drug name
Mebucaïne N, Lutschtabletten
Galenic form
LUTT
ATC Code
R02AA06
Authorization status
Z
Dispensing category
D
First authorization
26/10/2017
Authorization expiration date
31/12/9999
IT Number
12.03.3.
Domain
Human medicine
Field of application
Kurzfristige symptomatische Behandlung von Schmerzen bei leichten Entzündungen im Mund-Rachen-Raum.

Package details

Description (FR)
MEBUCAÏNE N cpr sucer 30 pce
Description (DE)
MEBUCAÏNE N Lutschtabl 30 Stk
Market launch
26/10/2017
Narcotic (BTM)
No

Other package sizes (2)

None
20 TABL
GTIN: None
Not in V1
None
1 TABL
GTIN: None
Not in V1